openPR Logo
Press release

Antimicrobial Susceptibility Testing Market to Reach USD 4.7 billion by 2027, at a CAGR of 5.5%

03-03-2023 07:08 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ReportsnReports

Antimicrobial Susceptibility Testing Market

Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing market is projected to reach USD 4.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 5.5% during the forecast period. The significant growth of the antimicrobial susceptibility testing market is largely due to the overuse and misuse of antibiotics, which resuresistance microbial resistances (AMR), and the increased use of antimicrobial susceptibility testing by biopharmaceutical, biotechnological, and pharmaceutical companies.

Get a Free Sample Copy of the Global Antimicrobial Susceptibility Testing Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1308641

"The automated laboratory instruments to hold the largest share of the market in 2022"

Automated laboratory instruments holds the largest market share in 2022. Automated identification and susceptibility systems are more expensive than manual conventional ones but offer the advantage of quicker findings. Although automated methods are more efficient and of higher quality, some bacteria and antimicrobial agents have specific technological limitations.

"The Antibacterial infections is holding the largest share of the market in 2022"

Based on type, the antimicrobial susceptibility testing market is classified into antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing and other susceptibility testing. The large share of this segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements in this segment, and the rising burden of antibacterial resistance in developing and developed countries.

Get a 25% Discount on the Global Antimicrobial Susceptibility Testing Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1308641

"The market in North America region is expected to witness the highest growth during the forecast period."

North America accounted for the largest market share-35.4%-in 2022. The increasing R&D to develop novel automated AST systems, rising prevalence of infectious diseases, growing safety concerns, and technological advancements in antimicrobial susceptibility testing products are the key factors supporting market growth in North America

While the APAC is expected to witness significant growth in the coming years. The antimicrobial susceptibility testing market in the APAC region is expected to register a CAGR of 6.7% during the forecast period, primarily due to the growing number of hospitals in Asian countries and favorable government initiatives.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
By Designation: C-level-27%, Director-level-18%, and Others-55%
By Region: North America-35.3%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%
The prominent player in Antimicrobial susceptibility testing are bio Mérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US)

Direct Purchase of the Global Antimicrobial Susceptibility Testing Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1308641

Research Coverage

This report studies the Antimicrobial susceptibility testing market based on product, product design, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

+ 1 347 333 3771
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antimicrobial Susceptibility Testing Market to Reach USD 4.7 billion by 2027, at a CAGR of 5.5% here

News-ID: 2958662 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Antimicrobial

Antimicrobial Packaging Market: An Overview
Antimicrobial packaging is a rapidly growing segment within the packaging industry, designed to inhibit the growth of harmful microorganisms. This innovative solution is gaining attention due to its ability to prolong the shelf life of products, enhance food safety, and reduce waste. The application of antimicrobial agents in packaging materials offers significant benefits across various sectors, including food and beverage, pharmaceuticals, and personal care. Market Size The antimicrobial packaging market is expected
Antimicrobial Peptides Beyond Traditional Antibiotics: The Antimicrobial Peptide …
Antimicrobial Peptides Market worth $532.02 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antimicrobial Peptides Market - (By Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides), By Ailments (Pneumonia, Hepatitis, Bacterial infections, HIV), By Route of Administration (Topical, Subcutaneous, Intravenous), By End User (Pharma and Healthcare, Agriculture Industry,
Antimicrobial Susceptibility Testing Market
Redding California,March 19, 2024 - Meticulous Research®, a distinguished leader in global market research, announces the release of its latest report titled "Antimicrobial Susceptibility Testing Market." This comprehensive study provides valuable insights into the market landscape, forecasting significant growth and pivotal trends shaping the industry landscape. Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5062 The Antimicrobial Susceptibility Testing Market is projected to burgeon to $5.99 billion by 2028, exhibiting a robust CAGR of approximately
Veterinary Antimicrobial Susceptibility Testing Market: Navigating Growth Amidst …
The Veterinary Antimicrobial Susceptibility Testing Market is poised for significant growth in the coming years, as per a recent report by Transparency Market Research. With a projected CAGR of nearly 7% from 2022 to 2032, the market is expected to reach a valuation of nearly US$ 76.2 billion by the end of the forecast period, up from around US$ 37.6 billion in 2021. The market growth is primarily driven by several
Antimicrobial Plastics Industry 2022-2026
The antimicrobial plastics market is projected to reach USD 66.7 billion by 2026, at a CAGR of 10.8% from USD 40.0 billion in 2021. Download FREE Sample Research Report of Antimicrobial Plastics Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=371217 The report provides a comprehensive analysis of company profiles listed below: • DuPont De Nemours Inc. (US) • BASF SE (Germany) • Microban International (US) • Sanitized AG (Switzerland) • BioCote Limited (UK) • Avient Corporation (US) • King Plastic Corporation (US) • Milliken Chemical (US) • Parx Plastics N.V (Netherlands) "The inorganic additive
Antimicrobial Additives Industry 2022-2026
The antimicrobial additives market is estimated to grow to USD 5.5 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 6.6%. Download FREE Sample Research Report of Antimicrobial Additives Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5462394 The report provides a comprehensive analysis of company profiles listed below: • BASF SE (Germany) • DuPont De Nemours (US) • Microban International (US) • Sanitized AG (Switzerland) • LyondellBasell (Netherlands) • Avient Corporation (US) • Biocote (UK) • RTP Company (US) • Milliken Chemical (US) There has been massive industrial growth in